Telman Deborah H 4
4 · GILEAD SCIENCES, INC. · Filed Oct 27, 2025
Insider Transaction Report
Form 4
Telman Deborah H
EVP, Corporate Affairs & GC
Transactions
- Tax Payment
Common Stock
2025-10-25$120.94/sh−241$29,147→ 43,676 total - Exercise/Conversion
Common Stock
2025-10-25+515→ 43,917 total - Exercise/Conversion
Restricted Stock Unit
2025-10-25−515→ 19,816 total→ Common Stock (515 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.